Mira Pharmaceuticals Inc

NAS:MIRA (USA)  
$ 0.98 +0.005 (+0.5%) 10:09 PM EST
At Loss
P/B:
1.82
Market Cap:
$ 14.78M
Enterprise V:
$ 9.76M
Volume:
70.31K
Avg Vol (2M):
223.14K
Also Trade In:
Volume:
70.31K
At Loss
Avg Vol (2M):
223.14K

Business Description

Description
Mira Pharmaceuticals Inc is an early pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic THC analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. Its target patient population is also typically presenting with chronic pain. its drug candidate, MIRA1a, if approved by the FDA, maybe a significant advancement in the treatment of neuropsychiatric, inflammatory, and neurologic diseases and disorders. Based on pre-clinical and animal studies conducted by the company, it believes that MIRA1a enhances the therapeutic potential for treating anxiety, cognitive decline and chronic pain.
Name Current Vs Industry Vs History
Cash-To-Debt 53.84
Equity-to-Asset 0.9
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 35.14
9-Day RSI 42.88
14-Day RSI 44.53
6-1 Month Momentum % -85.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.99
Quick Ratio 6.99
Cash Ratio 6.76

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -4.83
Name Current Vs Industry Vs History
ROE % -435.63
ROA % -214.03
ROIC % -286.64
ROC (Joel Greenblatt) % -3602.11
ROCE % -380.57

Financials (Next Earnings Date:2024-02-29 Est.)

MIRA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MIRA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Mira Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.529
Beta 0
Volatility % 0
14-Day RSI 44.53
14-Day ATR ($) 0.14378
20-Day SMA ($) 1.06571
12-1 Month Momentum % 0
52-Week Range ($) 0.79 - 7.9799
Shares Outstanding (Mil) 14.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mira Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Mira Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Mira Pharmaceuticals Inc Frequently Asked Questions

What is Mira Pharmaceuticals Inc(MIRA)'s stock price today?
The current price of MIRA is $0.98. The 52 week high of MIRA is $7.98 and 52 week low is $0.79.
When is next earnings date of Mira Pharmaceuticals Inc(MIRA)?
The next earnings date of Mira Pharmaceuticals Inc(MIRA) is 2024-02-29 Est..
Does Mira Pharmaceuticals Inc(MIRA) pay dividends? If so, how much?
Mira Pharmaceuticals Inc(MIRA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1